Business Description
Lin BioScience Inc
ISIN : TW0006696008
Share Class Description:
ROCO:6696: Ordinary SharesDescription
Lin BioScience Inc is a drug development company. It specializes in therapies for diseases with unmet medical needs. Its novel pipeline consists of first-in-class drugs aimed at treating life-threatening or disabling diseases in oncology, ophthalmology, cardiovascular, and metabolic disease.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 111.68 | |||||
| Equity-to-Asset | 0.56 | |||||
| Debt-to-Equity | 0.02 | |||||
| Debt-to-EBITDA | -0.03 | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -75.4 | |||||
| 3-Year EPS without NRI Growth Rate | -57.3 | |||||
| 3-Year FCF Growth Rate | -68.8 | |||||
| 3-Year Book Growth Rate | 27.9 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 28.03 | |||||
| 9-Day RSI | 34.29 | |||||
| 14-Day RSI | 39.61 | |||||
| 6-1 Month Momentum % | 51.84 | |||||
| 12-1 Month Momentum % | 21.74 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 32.95 | |||||
| Quick Ratio | 32.95 | |||||
| Cash Ratio | 31.7 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -3.9 | |||||
| Shareholder Yield % | -6 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -36.9 | |||||
| ROA % | -21.31 | |||||
| ROIC % | -582.77 | |||||
| ROC (Joel Greenblatt) % | -1510.05 | |||||
| ROCE % | -37.12 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 4.1 | |||||
| Price-to-Tangible-Book | 4.32 | |||||
| EV-to-EBIT | -6.65 | |||||
| EV-to-EBITDA | -6.77 | |||||
| EV-to-FCF | -5.6 | |||||
| Price-to-Net-Current-Asset-Value | 4.42 | |||||
| Price-to-Net-Cash | 4.76 | |||||
| Earnings Yield (Greenblatt) % | -15.03 | |||||
| FCF Yield % | -11.35 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Lin BioScience Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | |||
| EPS (TTM) (NT$) | -9.52 | ||
| Beta | 0.1 | ||
| Volatility % | 29.08 | ||
| 14-Day RSI | 39.61 | ||
| 14-Day ATR (NT$) | 5.530917 | ||
| 20-Day SMA (NT$) | 138.85 | ||
| 12-1 Month Momentum % | 21.74 | ||
| 52-Week Range (NT$) | 70 - 180.5 | ||
| Shares Outstanding (Mil) | 78.63 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Lin BioScience Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Lin BioScience Inc Stock Events
| Event | Date | Price(NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Lin BioScience Inc Frequently Asked Questions
What is Lin BioScience Inc(ROCO:6696)'s stock price today?
The current price of ROCO:6696 is NT$133.00. The 52 week high of ROCO:6696 is NT$180.50 and 52 week low is NT$70.00.
When is next earnings date of Lin BioScience Inc(ROCO:6696)?
The next earnings date of Lin BioScience Inc(ROCO:6696) is .
Does Lin BioScience Inc(ROCO:6696) pay dividends? If so, how much?
Lin BioScience Inc(ROCO:6696) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers